Fiscal Year Ending March 2026 Q3 Financial Summary [Japanese GAAP] (Consolidated)

Overview of Financial Performance

For the cumulative consolidated third quarter period of the fiscal year ending March 2026, net sales amounted to 87,594 million yen (7.5% Year-over-Year increase), operating income was 14,933 million yen (26.4% increase), ordinary income was 15,245 million yen (15.5% increase), and quarterly net income attributable to owners of parent was 35,110 million yen (272.7% increase). The electronic materials segment performed strongly, driving net sales of 36,087 million yen (19.5% increase) and operating income of 13,827 million yen (39.6% increase). The medical segment also remained steady with net sales of 10,322 million yen (0.1% increase) and operating income of 1,856 million yen (7.1% increase). By contrast, the materials & chemicals and thermal insulation segments experienced declines in both sales and profits.

Financial Position and Dividend Status

Total assets increased by 49,484 million yen from the previous consolidated fiscal year-end, reaching 272,589 million yen. Net assets were 171,358 million yen, and the equity ratio rose 2.4 points to 60.5%. Regarding dividends, the annual dividend forecast for the fiscal year ending March 2026 is 114 yen per share (interim 27.5 yen, year-end 86.5 yen) with no revisions from the most recent forecast.

Revision to Full-Year Earnings Forecast for Fiscal Year Ending March 2026

The full-year consolidated earnings forecast for the fiscal year ending March 2026 has been revised upward. Net sales are projected at 120,000 million yen (10.1% Year-over-Year increase), operating income at 20,000 million yen (21.6% increase), ordinary income at 20,000 million yen (13.8% increase), net income attributable to owners of parent at 38,000 million yen (196.0% increase), and net income per share at 1,043.79 yen.